Rivolution GmbH

Rivolution GmbH, based in Germany, specializes in innovative medical technology, providing surgical solutions that enhance operational outcomes and patient care in hospitals and surgical centers. Rivolution GmbH is a medical technology company focused on developing advanced surgical products. Founded in Rosenheim, Germany, the firm has not undergone any notable pivots. The company has been involved in one deal, with the most recent occurring on September 30, 2025, when Saesco Medical S.

L. , a portfolio company of Miura Partners, acquired Rivolution GmbH. Financial terms of the transaction were not disclosed. RiVOLUTiON GmbH specializes in innovative medical technology, offering a diverse range of products designed to enhance surgical outcomes and improve patient care.

Their flagship product, the SoniCure™ Ultrasound Surgical System, utilizes ultrasound energy for hemostatic cutting and safe coagulation of vessels and various tissue structures, providing a critical link in clinical surgical equipment. Additionally, their Klammernaht Portfolio includes advanced stapling solutions such as the ESI EndoFlex GEN III and Circular Stapler, designed to enhance safety and flexibility in surgical procedures. The company also introduces the AlpiTube™ concept for postoperative treatment following oncological rectal resections and the CRYO-S® Painless Kryoanalgesia, revolutionizing pain management in thoracic surgery. RiVOLUTiON's products cater primarily to healthcare professionals and institutions in Europe, North America, and select markets in Asia, focusing on hospitals and specialized surgical centers.

RiVOLUTiON GmbH generates revenue through direct sales of its proprietary medical devices and technology to healthcare providers, predominantly in a B2B model. The company engages in transactional relationships with hospitals, surgical centers, and distributors, ensuring that their advanced medical products reach end-users effectively. Their pricing structure is tailored to reflect the cutting-edge nature of their offerings, which include trademarked solutions such as the SoniCure™ and CRYO-S®. Revenue is derived from individual product sales as well as potential long-term partnerships with healthcare institutions that may involve bulk purchasing agreements.

These transactions are structured to facilitate efficient delivery and support for the end-users, ultimately enhancing operational outcomes in surgical settings. With the acquisition by Saesco Medical S. L. on September 30, 2025, Rivolution GmbH is poised for strategic growth.

The company plans to leverage its innovative product portfolio to enhance business development initiatives. Future growth will focus on expanding into new geographic regions, particularly targeting additional markets in Europe and Asia. The recent acquisition will provide the necessary resources to support these growth strategies.